Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer	Disease Attributes, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm	Recruiting	Not stated	2026-08-18		NCT06993506

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	294

19 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Hospital, Chinese Academy of Medical Sciences	Beijing	China	41
Chinese PLA General Hospital	Beijing	China	87
Fujian Cancer Hospital	Fuzhou	China	18
Hubei Cancer Hospital	Wuhan	China	95
Peking University First Hospital	Beijing	China	163
Shanxi Bethune Hospital	Taiyuan	China	26
Suining Central Hospital	Suining	China	15
Taihe Hospital	Shiyan	China	1
The Affiliated People's Hospital of Ningbo University	Ningbo	China	1
The First Affiliated Hospital Of Xiamen University	Xiamen	China	50
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
The First Hospital of Jilin University	Changchun	China	110
The First People's Hospital of Changde City	Changde	China	3
The Fourth Hospital of Hebei Medical University	Shijiazhuang	China	33
The Second Affiliated Hospital of Anhui Medical University	Hefei	China	16
The Third People's Hospital of Zhengzhou	Zhengzhou	China	5
Union Hospital Tongji Medical College Huazhong University of Science and Technology	Wuhan	China	30
Yantai Yuhuangding Hospital	Yantai	China	30
Zhongshan Hospital Fudan University	Shanghai	China	38